Offering includes five-year warrants; Laidlaw & Co. (UK) is the agent
By Devika Patel
Knoxville, Tenn., Sept. 15 – BioSig Technologies, Inc. completed a $390,000 second and final tranche of a $953,000 private placement of stock on Sept. 12, according to an 8-K filed Monday with the Securities and Exchange Commission. Laidlaw & Co. (UK) Ltd. was the agent for the deal, which raised $563,000 on Aug. 15 and was slated to raise up to $1 million.
The company sold 381,200 common shares at $2.50 apiece. The investors also received five-year warrants for 190,600 shares, which are each exercisable at $2.75.
In the initial tranche, the company sold 225,200 shares and warrants for 112,600 shares. It sold 156,000 shares and warrants for 78,000 shares in the second tranche.
The private medical device company is based in Los Angeles.
| Issuer: | BioSig Technologies, Inc.
|
| Issue: | Common shares
|
| Amount: | $953,000
|
| Shares: | 381,200
|
| Price: | $2.50
|
| Warrants: | For 190,600 shares
|
| Warrant expiration: | Five years
|
| Warrant strike price: | $2.75
|
| Agent: | Laidlaw & Co. (UK) Ltd.
|
| Settlement date: | Aug. 15 (for $563,000), Sept. 12 (for $390,000)
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
